Pfizer to Require Office Work Two or Three Times a Week Starting January

Pfizer Inc.’s US employees will be required to return to their workplaces two to three days a week starting in January, Chief Executive Officer Albert Bourla said.

Almost three years after the pandemic began, about a third of Pfizer employees still have not been back to the office, Bourla said Tuesday in a panel discussion at the Paley International Council Summit in New York. Pfizer teamed with BioNTech SE to develop highly effective Covid-19 vaccines at top speed during the pandemic, when many employees were working from home, and then generated the Paxlovid pill for treating people at high risk of severe disease. Both products have been highly successful for the company.